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The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly
involving M. pneumoniae type 1 strains.
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Abstract
An increased incidence of Mycoplasma pneumoniae infections was reported in 2011 in two cities in France, Bordeaux and Caen. Two
complementary molecular typing methods, PCR-RFLP on adhesin P1 and multilocus variable number tandem repeat analysis (MLVA), were
used to determine whether this phenomenon was clonal. In 2011, the percentage of M. pneumoniae-positive patients doubled in both cities
compared with 2010. Macrolide resistance remained stable at 8.3% of patients. Eighteen MLVA types were identiﬁed among
94 M. pneumoniae-positive specimens, demonstrating that the phenomenon was multiclonal. Types P, J, U, X and E were the most frequent
and 81.6% of the strains were adhesin P1 type 1.
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Abstract
A prospective observational nationwide investigation was performed from September 2005 to August 2006 to study the epidemiology of
candidaemia in Sweden. From 385 patients, 403 isolates were recovered, yielding an incidence of 4.2 cases per 100 000 inhabitants. Candida
albicans was the most common species (61%), followed by Candida glabrata (20%) and Candida parapsilosis (9%). The rates of resistance to
ﬂuconazole were  1% in C. albicans and 6–29% in non-albicans species other than C. glabrata and Candida krusei. Resistance to voriconazole
was rare, except for C. glabrata and C. krusei. Only three isolates had reduced susceptibility to amphotericin B, and one had reduced
susceptibility to caspofungin.
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